fomesafen has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guiba-Tziampiri, O; Kaiki-Astara, A; Karkavelas, G; Papoutsopoulou, S; Simeonidou, C; Soubasi, V; Spandou, E | 1 |
| Barbier, EL; Bernaudin, M; Bouzat, P; Fevre, MC; Francony, G; Lahrech, H; Mauconduit, F; Payen, JF; Thomas, S; Valable, S | 1 |
| Caravagna, C; Khemiri, H; Seaborn, T; Soliz, J | 1 |
1 review(s) available for fomesafen and losartan potassium
| Article | Year |
|---|---|
Erythropoietin and the sex-dimorphic chemoreflex pathway.
Topics: Animals; Carotid Body; Chemoreceptor Cells; Erythropoietin; Humans; Hypoxia; Reflex; Respiration; Sex Characteristics | 2012 |
2 other study(ies) available for fomesafen and losartan potassium
| Article | Year |
|---|---|
Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Disease Models, Animal; DNA Fragmentation; Erythropoietin; Female; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reflex | 2004 |
Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative.
Topics: Animals; Brain; Brain Edema; Brain Injuries; Cognition Disorders; Erythropoietin; Magnetic Resonance Imaging; Male; Psychomotor Disorders; Rats; Rats, Wistar; Reflex; Time Factors | 2011 |